SCHEMBL15026091

SCHEMBL15026091

COC1CC(/C=C/C2CC(O)CC(/C=C/C3CCC(O)C(OC)C3)C2)CCC1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12252370 0.88
SCHEMBL15508460 0.81
SCHEMBL16907235 0.81
SCHEMBL15026082 0.81
SCHEMBL12253293 0.77 LMNA (0.30)
SCHEMBL17435720 0.76 FKBP1A (0.31)
SCHEMBL12252365 0.76 IDO1 (0.33)
SCHEMBL13323840 0.75 FKBP1A (0.31)
SCHEMBL12253292 0.72 LMNA (0.30)
SCHEMBL19456316 0.72 LMNA (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170224637-A1 INTRANSAL DELIVERY OF CURCUMIN DePuy Synthes Products, Inc. (US) 2017-08-10 US disclosed
EP-2749552-A1 Curcumin-resveratrol hybrids Codman & Shurtleff, Inc. (US) 2014-07-02 EP disclosed
US-20140163116-A1 METHOD OF TREATING CANCER USING A CURCUMIN DERIVATIVE DePuy Synthes Products, LLC (US) 2014-06-12 US disclosed
US-20130150628-A1 PHARMACEUTICAL COMPOSITION COMPRISING A CURCUMIN DERIVATIVE DIMAURO THOMAS M (US) 2013-06-13 US disclosed